Total Payments
$1.3M
2024 Payments
$237,508
Companies
32
Transactions
785
Medicare Patients
5,072
Medicare Billing
$488,976
Payment Breakdown by Category
Research$787,910 (60.4%)
Other$301,172 (23.1%)
Consulting$143,492 (11.0%)
Travel$51,449 (3.9%)
Food & Beverage$20,339 (1.6%)
Education$38.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $787,910 | 36 | 60.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $296,177 | 110 | 22.7% |
| Consulting Fee | $143,492 | 74 | 11.0% |
| Travel and Lodging | $51,449 | 183 | 3.9% |
| Food and Beverage | $20,339 | 376 | 1.6% |
| Honoraria | $3,900 | 3 | 0.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $950.00 | 1 | 0.1% |
| Entertainment | $145.26 | 1 | 0.0% |
| Education | $38.00 | 1 | 0.0% |
Payments by Type
Research
$787,910
36 transactions
General
$516,490
749 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurent Medical Limited | $278,063 | 11 | $0 (2024) |
| Hill Dermaceuticals, Inc. | $276,881 | 1 | $0 (2021) |
| Spirox Inc | $225,709 | 13 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $143,580 | 180 | $0 (2024) |
| Optinose US, Inc. | $112,636 | 174 | $0 (2024) |
| GlaxoSmithKline, LLC. | $73,627 | 70 | $0 (2024) |
| Stryker Corporation | $48,470 | 85 | $0 (2024) |
| Arrinex, Inc. | $43,569 | 12 | $0 (2018) |
| AERIN MEDICAL INC. | $33,188 | 42 | $0 (2024) |
| Intersect ENT, Inc. | $13,009 | 45 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237,508 | 142 | Neurent Medical Limited ($103,710) |
| 2023 | $261,430 | 167 | Neurent Medical Limited ($160,605) |
| 2022 | $65,801 | 83 | GlaxoSmithKline, LLC. ($28,696) |
| 2021 | $312,780 | 59 | Hill Dermaceuticals, Inc. ($276,881) |
| 2020 | $48,435 | 73 | OptiNose US, Inc. ($21,450) |
| 2019 | $85,386 | 164 | Stryker Corporation ($38,982) |
| 2018 | $22,766 | 46 | Stryker Corporation ($9,168) |
| 2017 | $270,294 | 51 | Spirox Inc ($225,709) |
All Payment Transactions
785 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Consulting Fee | Cash or cash equivalent | $13,950.00 | General |
| Category: EAR NOSE & THROAT | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/10/2024 | LivaNova USA, Inc. | THN Sleep Therapy (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $637.50 | General |
| 11/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $128.74 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $74.94 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $37.86 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $292.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: EAR NOSE & THROAT | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $1,144.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,400.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,744.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $83.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $848.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $767.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/12/2024 | LivaNova USA, Inc. | THN Sleep Therapy (Device) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Neurology | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $219.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) | Hill Dermaceuticals, Inc. | $276,881 | 1 |
| Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | Neurent Medical Limited | $171,154 | 4 |
| SpiroxLatera Implant Support of Lateral Nasal Wall Cartilage LATERAL-OFFICE Study | Spirox Inc | $164,233 | 5 |
| SpiroxLatera Implant Support of Lateral Nasal Wall Cartilage LATERAL-OR Study | Spirox Inc | $60,315 | 5 |
| Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | Neurent Medical Limited | $38,383 | 1 |
| NEUROMARK Randomized Controlled Trial | Neurent Medical Limited | $25,720 | 1 |
| NEUROMARK Registry Study | Neurent Medical Limited | $21,864 | 2 |
| Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | Neurent Medical Limited | $20,872 | 2 |
| A PHASE III, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, A PHASE III, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS | F. Hoffmann-La Roche AG | $6,076 | 8 |
| Insmed BIRCH Study | Insmed, Inc. | $1,489 | 6 |
| A PhIII RANDOMIZED TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS and PH3 RANDOMIZED MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF OMALIZUMAB FOR NASAL POLYPS | F. Hoffmann-La Roche AG | $923.43 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,211 | 1,416 | $587,732 | $142,653 |
| 2022 | 15 | 1,337 | 1,559 | $489,891 | $123,134 |
| 2021 | 13 | 1,307 | 1,512 | $443,610 | $113,964 |
| 2020 | 14 | 1,217 | 1,388 | $473,803 | $109,224 |
Total Patients
5,072
Total Services
5,875
Medicare Billing
$488,976
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 30469 | Repair of collapsed nasal valve | Office | 2023 | 15 | 15 | $125,175 | $32,581 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 283 | $96,503 | $26,458 | 27.4% |
| 30117 | Removal or destruction of growth of nose through nose | Office | 2023 | 18 | 36 | $76,302 | $16,785 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $59,455 | $13,796 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 121 | 121 | $41,140 | $10,167 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 107 | $24,717 | $7,608 | 30.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 37 | 42 | $29,358 | $6,628 | 22.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 61 | 63 | $23,373 | $6,487 | 27.8% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 172 | 186 | $21,576 | $5,390 | 25.0% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 45 | 46 | $33,764 | $4,937 | 14.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 75 | 119 | $19,635 | $4,321 | 22.0% |
| 92567 | Test to assess middle ear function | Office | 2023 | 163 | 176 | $7,920 | $2,344 | 29.6% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 58 | 58 | $9,802 | $2,332 | 23.8% |
| 30801 | Destruction of soft tissue of nasal passages | Office | 2023 | 16 | 16 | $12,416 | $1,548 | 12.5% |
| 42975 | Evaluation of sleep-disordered breathing by examination of upper airway using an endoscope | Facility | 2023 | 13 | 13 | $4,576 | $787.93 | 17.2% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 15 | 20 | $2,020 | $483.55 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 350 | $119,350 | $34,303 | 28.7% |
| 30117 | Removal or destruction of growth of nose through nose | Office | 2022 | 13 | 26 | $55,107 | $17,066 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 112 | 112 | $57,904 | $14,222 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 151 | 151 | $51,340 | $11,402 | 22.2% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 49 | 58 | $40,542 | $8,782 | 21.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 74 | 79 | $29,309 | $8,335 | 28.4% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 186 | 197 | $22,852 | $5,578 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 91 | $21,021 | $5,349 | 25.4% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 45 | 46 | $33,764 | $5,343 | 15.8% |
About Randall Ow
Randall Ow is a Otolaryngology healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336142009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Randall Ow has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $237,508 received in 2024. These payments were reported across 785 transactions from 32 companies. The most common payment nature is "" ($787,910).
As a Medicare-enrolled provider, Ow has provided services to 5,072 Medicare beneficiaries, totaling 5,875 services with total Medicare billing of $488,976. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Roseville, CA
- Active Since 05/24/2005
- Last Updated 06/16/2018
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1336142009
Products in Payments
- NEUROMARK Device (Device) $278,063
- Latera (Device) $225,709
- DUPIXENT (Biological) $144,754
- Xhance (Drug) $112,595
- NUCALA (Biological) $73,627
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $44,301
- Clarifix (Device) $43,569
- Xolair (Biological) $28,480
- VIVAER STYLUS (Device) $23,801
- VivAer (Device) $6,692
- Sinuva (Drug) $5,300
- SPIROX - LATERA (Device) $3,889
- THN Sleep Therapy (Device) $3,320
- No Product (Device) $3,081
- DUPIXENT (Drug) $2,484
- TULA System (Device) $2,079
- RHINAER STYLUS (Device) $1,500
- PROPEL (Device) $1,277
- STRAIGHTSHOT (Device) $950.00
- TULA (Device) $900.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Roseville
Dr. Aaron Centric, D.o, D.O
Otolaryngology — Payments: $6,684
Otolaryngology $6,684
Tim Fife, Md, MD
Otolaryngology — Payments: $2,692
Otolaryngology $2,692
Daniel Chung
Otolaryngology — Payments: $891.79
Otolaryngology $891.79
Charles Gage, Md, MD
Otolaryngology — Payments: $829.47
Otolaryngology $829.47
Dr. Danielle Anderson, Do, DO
Otolaryngology — Payments: $245.06
Otolaryngology $245.06
Dr. Eric Ro, M.d, M.D
Otolaryngology — Payments: $217.66
Otolaryngology $217.66